Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dentsply Sirona
(NASDAQ:XRAY)
Intraday
$27.89
-0.31
[-1.10%]
After-Hours
$27.89
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$27.89
-0.31
[-1.10%]
At close: May 10
$27.89
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Dentsply Sirona Stock (NASDAQ:XRAY)
Dentsply Sirona Stock (NASDAQ: XRAY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, May 06, 2024
Key Takeaways From Dentsply Sirona Analyst Ratings
Benzinga Insights
-
4 days ago
Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $30
Benzinga Newsdesk
-
5 days ago
Friday, May 03, 2024
Evercore ISI Group Maintains Outperform on Dentsply Sirona, Lowers Price Target to $35
Benzinga Newsdesk
-
May 3, 2024, 12:24PM
Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $38
Benzinga Newsdesk
-
May 3, 2024, 10:04AM
Piper Sandler Reiterates Neutral on Dentsply Sirona, Lowers Price Target to $32
Benzinga Newsdesk
-
May 3, 2024, 9:19AM
Baird Maintains Neutral on Dentsply Sirona, Lowers Price Target to $33
Benzinga Newsdesk
-
May 3, 2024, 7:03AM
Needham Maintains Buy on Dentsply Sirona, Lowers Price Target to $36
Benzinga Newsdesk
-
May 3, 2024, 6:20AM
Thursday, May 02, 2024
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Avi Kapoor
-
May 2, 2024, 2:45PM
Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why
Nabaparna Bhattacharya
-
May 2, 2024, 12:46PM
Dentsply Sirona shares are trading lower following a Q1 revenue miss.
Benzinga Newsdesk
-
May 2, 2024, 6:08AM
Dentsply Sirona Expects To Repurchase Up To $150M Of Its Common Stock In Q2 2024
Benzinga Newsdesk
-
May 2, 2024, 6:07AM
Dentsply Sirona Maintains FY24 Outlook For Organic Sales And Adjusted EPS, Trending Towards The Low-End Of Both Ranges
Benzinga Newsdesk
-
May 2, 2024, 6:06AM
Dentsply Sirona Q1 2024 Adj EPS $0.42, Inline, Sales $953.000M Miss $969.136M Estimate
Benzinga Newsdesk
-
May 2, 2024, 6:02AM
Thursday, April 18, 2024
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Benzinga Insights
-
Apr 18, 2024, 10:00AM
Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $41 Price Target
Benzinga Newsdesk
-
Apr 18, 2024, 9:38AM
Wednesday, March 27, 2024
Dentsply Sirona To Move To S&P MidCap 400, Effective Prior To The Open Of Trading On April 3; GE Vernova To Be Added To S&P 500 Replacing Dentsply Sirona
Benzinga Newsdesk
-
Mar 27, 2024, 5:27PM
Friday, March 01, 2024
Barrington Research Reiterates Outperform on Dentsply Sirona, Maintains $41 Price Target
Benzinga Newsdesk
-
Mar 1, 2024, 10:47AM
Thursday, February 29, 2024
Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews
Benzinga Insights
-
Feb 29, 2024, 3:01PM
Needham Reiterates Buy on Dentsply Sirona, Maintains $42 Price Target
Benzinga Newsdesk
-
Feb 29, 2024, 2:54PM
Dentsply Sirona Announced The Retirement Of Eric K. Brandt, A Director On The Company's Board Of Directors At The May 2024 Annual Meeting
Benzinga Newsdesk
-
Feb 29, 2024, 6:42AM
Dentsply Sirona's Board Of Directors Approved A 14% Increase In Quarterly Dividend, From $0.14/Share To $0.16/Share. The Dividend Is Payable On April 12, 2024, To Holders Of Record As Of March 29, 2024
Benzinga Newsdesk
-
Feb 29, 2024, 6:08AM
Dentsply Sirona Forecasts Fiscal Year 2024 Sales Of $3.96B-$4.02B Versus Consensus Of $4.00B And Adjusted EPS Of $2.00-$2.10 Versus Consensus Of $2.05
Benzinga Newsdesk
-
Feb 29, 2024, 6:06AM
Dentsply Sirona Q4 Adjusted EPS $0.44 Beats $0.43 Estimate, Sales $1.01B Beat $976.87M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 6:04AM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Monday, February 26, 2024
Leerink Partners Initiates Coverage On Dentsply Sirona with Outperform Rating, Announces Price Target of $42
Benzinga Newsdesk
-
Feb 26, 2024, 8:26AM
Friday, January 12, 2024
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $35
Benzinga Newsdesk
-
Jan 12, 2024, 11:02AM
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits
Benzinga Insights
-
Jan 12, 2024, 10:05AM
Tuesday, January 09, 2024
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Benzinga Insights
-
Jan 9, 2024, 2:00PM
Needham Maintains Buy on Dentsply Sirona, Raises Price Target to $42
Benzinga Newsdesk
-
Jan 9, 2024, 11:04AM
Monday, December 25, 2023
Wednesday Is Your Last Chance To Buy Dentsply Sirona Before The Dividend Payout
Benzinga Insights
-
Dec 25, 2023, 9:45AM
Tuesday, November 28, 2023
Dentsply Sirona Insider Trades Send a Signal
Benzinga Insights
-
Nov 28, 2023, 10:02AM
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Lisa Levin
-
Nov 28, 2023, 8:44AM
Thursday, November 16, 2023
This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Vandana Singh
-
Nov 16, 2023, 12:43PM
Needham Initiates Coverage On Dentsply Sirona with Buy Rating, Announces Price Target of $35
Benzinga Newsdesk
-
Nov 16, 2023, 7:08AM
Monday, November 13, 2023
Stifel Maintains Hold on Dentsply Sirona, Lowers Price Target to $32-Report released on 12th Nov 2023
Benzinga Newsdesk
-
Nov 13, 2023, 10:44AM
Stifel Maintains Hold on Dentsply Sirona, Lowers Price Target to $32
Benzinga Newsdesk
-
Nov 13, 2023, 10:20AM
Friday, November 10, 2023
William Blair Upgrades Dentsply Sirona to Outperform
Benzinga Newsdesk
-
Nov 10, 2023, 6:56AM
Thursday, November 09, 2023
DENTSPLY SIRONA Announced That Its Board Of Directors Has Authorized An Additional $1B Share Repurchase Program
Benzinga Newsdesk
-
Nov 9, 2023, 8:06AM
Tuesday, November 07, 2023
Expert Ratings for Dentsply Sirona
Benzinga Insights
-
Nov 7, 2023, 3:00PM
Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $36
Benzinga Newsdesk
-
Nov 7, 2023, 9:42AM
Friday, November 03, 2023
Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $41
Benzinga Newsdesk
-
Nov 3, 2023, 5:29PM
Morgan Stanley Maintains Overweight on Dentsply Sirona, Lowers Price Target to $39
Benzinga Newsdesk
-
Nov 3, 2023, 8:49AM
Thursday, November 02, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 2, 2023, 2:26PM
Dentsply Sirona Sees FY23 Adjusted EPS Of $1.80-$1.85 Compared To Prior Guidance Of $1.92-$2.02 And Consensus Of $1.98
Benzinga Newsdesk
-
Nov 2, 2023, 6:23AM
Dentsply Sirona Revised FY23 Organic Sales Growth Of Approximately 1%, With Sales Of $3.90B-$3.94B Compared To Prior Guidance Of Around 3% And Consensus Of $4.01B
Benzinga Newsdesk
-
Nov 2, 2023, 6:22AM
Dentsply Sirona Q3 Adjusted EPS $0.49 Beats $0.48 Estimate, Sales $947.00M Miss $975.68M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 6:04AM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Stifel Maintains Hold on Dentsply Sirona, Lowers Price Target to $35
Benzinga Newsdesk
-
Nov 1, 2023, 3:28PM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
Friday, October 20, 2023
Morgan Stanley Maintains Overweight on Dentsply Sirona, Lowers Price Target to $43
Benzinga Newsdesk
-
Oct 20, 2023, 8:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch